Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Reproductive Biology and Endocrinology
Published in: Reproductive Biology and Endocrinology 1/2013

Open Access 01-12-2013 | Review

The management of Asherman syndrome: a review of literature

Authors: Alessandro Conforti, Carlo Alviggi, Antonio Mollo, Giuseppe De Placido, Adam Magos

Published in: Reproductive Biology and Endocrinology | Issue 1/2013

Login to get access

Abstract

Asherman syndrome is a debatable topic in gynaecological field and there is no clear consensus about management and treatment. It is characterized by variable scarring inside the uterine cavity and it is also cause of menstrual disturbances, infertility and placental abnormalities. The advent of hysteroscopy has revolutionized its diagnosis and management and is therefore considered the most valuable tool in diagnosis and management. The aim of this review is to explore the most recent evidence related to this condition with regards to aetiology, diagnosis management and follow up strategies.
Appendix
Available only for authorised users
Literature
1.
Asherman JG: Amenorrhoea traumatica (atretica). J Obstet Gynaecol Br Emp. 1948, 55: 23-30. 10.1111/j.1471-0528.1948.tb07045.x.CrossRefPubMed
2.
Asherman JG: Traumatic intrauterine adhesions. J Obstet Gynaecol Br Emp. 1950, 57: 892-896. 10.1111/j.1471-0528.1950.tb06053.x.CrossRefPubMed
3.
Yu D, Wong YM, Cheong Y, Xia E, Li TC: Asherman syndrome-one century later. Fertil Steril. 2008, 89: 759-779. 10.1016/j.fertnstert.2008.02.096.CrossRefPubMed
4.
Deans R, Abbott J: Review of intrauterine adhesions. J Minim Invasive Gynecol. 2010, 17: 555-569. 10.1016/j.jmig.2010.04.016.CrossRefPubMed
5.
Schenker JG, Margalioth EJ: Intrauterine adhesions: an updated appraisal. Fertil Steril. 1982, 37: 593-610.PubMed
6.
Al-Inany H: Intrauterine adhesions: an update. Acta Obstet Gynecol Scand. 2001, 80: 986-993.PubMed
7.
Chen Y, Chang Y, Yao S: Role of angiogenesis in endometrial repair of patients with severe intrauterine adhesion. Int J Clin Exp Pathol. 2013, 15: 1343-1350.
8.
Polishuk WZ, Kohane S: Intrauterine adhesions: diagnosis and therapy. Obstet Gynecol Digest. 1966, 8: 41-
9.
Malhotra N, Bahadur A, Kalaivani M, Mittal S: Changes in endometrial receptivity in women with Asherman’s syndrome undergoing hysteroscopic adhesiolysis. Arch Gynecol Obstet. 2012, 286: 525-530. 10.1007/s00404-012-2336-0.CrossRefPubMed
10.
Tao Z, Duan H: Expression of adhesion-related cytokines in the uterine fluid after transcervical resection of adhesion. Zhonghua Fu Chan Ke Za Zhi. 2012, 47: 734-737.PubMed
11.
Stillman RJ, Asarkof N: Association between mullerian duct malformations and Asherman syndrome in infertile women. Obstet Gynecol. 1985, 65: 673-677.PubMed
12.
Mara M, Fucikova Z, Kuzel J, Maskova P, Dund P, Zizka Z: Hysteroscopy after uterine fibroid embolization in woman of fertile age. J Obstet Gynaecol Res. 2007, 195: 1266-1271.
13.
Taskin O, Sadik S, Onoglu A, Gokdeniz R, Erturan E, Burak K, Wheeler JM: Role of endometrial suppression on the frequency of intrauterine adhesions after resectoscopic surgery. J Am Assoc Gynecol Laparosc. 2000, 7: 351-354. 10.1016/S1074-3804(05)60478-1.CrossRefPubMed
14.
Leung PL, Tam WH, Yuen PM: Hysteroscopic appearance of the endometrial cavity following thermal balloon endometrial ablation. Fertil Steril. 2003, 79: 1226-1228. 10.1016/S0015-0282(02)04956-7.CrossRefPubMed
15.
Ibrahim MI, Raafat TA, Ellaithy MI, Aly RT: Risk of postpartum uterine synechiae following uterine compression suturing during postpartum haemorrhage. Aust N Z J Obstet Gynaecol. 2013, 53: 37-45. 10.1111/ajo.12017.CrossRefPubMed
16.
Polishuk WZ, Anteby SO, Weinstein D: Puerperal endometritis and intrauterine adhesions. Int Surg. 1975, 60: 418-420.PubMed
17.
Romer T: Post-abortion-hysteroscopy—a method for early diagnosis of congenital and acquired intrauterine causes of abortions. Eur J Obstet Gynecol Reprod Biol. 1994, 57: 171-173. 10.1016/0028-2243(94)90295-X.CrossRefPubMed
18.
Shaffer W: Role of uterine adhesions in the cause of multiple pregnancy losses. Clin Obstet Gynecol. 1986, 29: 912-924. 10.1097/00003081-198612000-00016.CrossRefPubMed
19.
Bukulmez O, Yarali H, Gurgan T: Total corporal synechiae due to tuberculosis carry a very poor prognosis following hysteroscopic synechialysis. Hum Reprod. 1999, 14: 1960-1961. 10.1093/humrep/14.8.1960.CrossRefPubMed
20.
Krolikowski A, Janowski K, Larsen JV: Asherman syndrome caused by schistosomiasis. Obstet Gynecol. 1995, 85: 898-899. 10.1016/0029-7844(94)00371-J.CrossRefPubMed
21.
Wamsteker K, Blok SD: Diagnostic hysteroscopy: technique and documentation. Endoscopic surgery for gynecologists. Edited by: Sutton C, Diamond M. 1993, Philadelphia, PA: WB Saunders
22.
Salle B, Gaucherand P, de Saint Hilaire P, Rudigoz RC: Transvaginal sonohysterographic evaluation of intrauterine adhesions. J Clin Ultrasound. 1999, 27: 131-134. 10.1002/(SICI)1097-0096(199903/04)27:3<131::AID-JCU5>3.0.CO;2-3.CrossRefPubMed
23.
Sylvestre C, Child TJ, Tulandi T, Tan SL: A prospective study to evaluate the efficacy of two- and three-dimensional sonohysterography in women with intrauterine lesions. Fertil Steril. 2003, 79: 1222-1225. 10.1016/S0015-0282(03)00154-7.CrossRefPubMed
24.
Soares SR, Barbosa dos Reis MM, Camargos AF: Diagnostic accuracy of sonohysterography, transvaginal sonography, and hysterosalpingography in patients with uterine cavity diseases. Fertil Steril. 2000, 73: 406-411. 10.1016/S0015-0282(99)00532-4.CrossRefPubMed
25.
Hajishaiha M, Ghasemi-Rad M, Karimpour N, Mladkova N, Boromand F: Transvaginal sonographic evaluation at different menstrual cycle phases in diagnosis of uterine lesions. Int J Womens Health. 2011, 3: 353-357.PubMedCentralPubMed
26.
Kresowik JD, Syrop CH, Van Voorhis BJ, Ryan GL: Ultrasound is the optimal choice for guidance in difficult hysteroscopy. Ultrasound Obstet Gynecol. 2012, 39: 715-718. 10.1002/uog.11072.CrossRefPubMed
27.
Schlaff WD, Hurst BS: Preoperative sonographic measurement of endometrial pattern predicts outcome of surgical repair in patients with severe Asherman’s syndrome. Fertil Steril. 1995, 63: 410-413.PubMed
28.
Knopman J, Copperman AB: Value of 3D ultrasound in the management of suspected Asherman’s syndrome. J Reprod Med. 2007, 52: 1016-1022.PubMed
29.
Acholonu UC, Silberzweig J, Stein DE, Keltz M: Hysterosalpingography versus sonohysterography for intrauterine abnormalities. JSLS. 2011, 15: 471-474. 10.4293/108680811X13176785203923.PubMedCentralCrossRefPubMed
30.
Makris N, Kalmantis K, Skartados N, Papadimitriou A, Mantzaris G, Antsaklis A: Three-dimensional hysterosonography versus hysteroscopy for the detection of intracavitary uterine abnormalities. Int J Gynecol Obstet. 2007, 97: 6-9. 10.1016/j.ijgo.2006.10.012.CrossRef
31.
Abou-Salem N, Elmazny A, El-Sherbiny W: Value of 3-dimensional sonohysterography for detection of intrauterine lesions in women with abnormal uterine bleeding. J Minim Invasive Gynecol. 2010, 17: 200-204. 10.1016/j.jmig.2009.12.010.CrossRefPubMed
32.
Bacelar AC, Wilcock D, Powell M, Worthington BS: The value of MRI in the assessment of traumatic intra-uterine adhesions (Asherman’s syndrome). Clin Radiol. 1995, 50: 80-83. 10.1016/S0009-9260(05)82984-8.CrossRefPubMed
33.
Sugimoto O: Diagnostic and therapeutic hysteroscopy for traumatic intrauterine adhesions. Am J Obstet Gynecol. 1978, 131: 539-547.PubMed
34.
Toaff R, Ballas S: Traumatic hypomenorrhea-amenorrhea (Asherman’ syndrome). Fertil Steril. 1978, 30: 379-387.PubMed
35.
March C, Israel R, March A: Hysteroscopic management of intrauterine adhesions. Am J Obstet Gynecol. 1978, 130: 653-657.PubMed
36.
Nasr AL, Al-Inany HG, Thabet SM, Aboulghar MA: Clinicohysteroscopic scoring system of intrauterine adhesions. Gynecol Obstet Invest. 2000, 50: 178-181. 10.1159/000010305.CrossRefPubMed
37.
The American Fertility Society: Classifications of adnexal adhesions, distal tubal occlusion, tubal occlusion secondary to tubal ligation, tubal pregnancies, Mullerian anomalies and intrauterine adhesions. Fertil Steril. 1988, 49: 944-955.
38.
Reddy S, Rock JA: Surgical management of complete obliteration of the endometrial cavity. Fertil Steril. 1997, 67: 172-174. 10.1016/S0015-0282(97)81877-8.CrossRefPubMed
39.
Levine RU, Neuwirth RS: Simultaneous laparoscopy and hysteroscopy for intrauterine adhesions. Obstet Gynecol. 1973, 42: 441-445.PubMed
40.
Broome JD, Vancaillie TG: Fluoroscopically guided hysteroscopic division of adhesions in severe Asherman syndrome. Obstet Gynecol. 1999, 93: 1041-1043. 10.1016/S0029-7844(99)00245-8.CrossRefPubMed
41.
Valle RF, Sciarra JJ: Intrauterine adhesions: hysteroscopic diagnosis classification, treatment, and reproductive outcome. Am J Obstet Gynecol. 1988, 158: 1459-1470. 10.1016/0002-9378(88)90382-1.CrossRefPubMed
42.
Chervenak FA, Neuwirth RS: Hysteroscopic resection of the uterine septum. Am J Obstet Gynecol. 1981, 141: 351-353.PubMed
43.
DeCherney A, Polan ML: Hysteroscopic management of intrauterine lesions and intractable uterine bleeding. Obstet Gynecol. 1983, 61: 392-397.PubMed
44.
Capella-Allouc S, Morsad F, Rongieres-Bertrand C, Taylor S, Fernandez H: Hysteroscopic treatment of severe Asherman’s syndrome and subsequent fertility. Hum Reprod. 1999, 14: 1230-1233. 10.1093/humrep/14.5.1230.CrossRefPubMed
45.
Zikopoulos KA, Kolibianakis EM, Platteau P, de Munck L, Tournaye H, Devroey P, Camus M: Live delivery rates in subfertile women with Asherman’s syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. Reprod Biomed Online. 2004, 8: 720-725. 10.1016/S1472-6483(10)61654-9.CrossRefPubMed
46.
Chapman R, Chapman K: The value of two stage laser treatment for severe Asherman’s syndrome. Br J Obstet Gynaecol. 1996, 103: 1256-1258. 10.1111/j.1471-0528.1996.tb09641.x.CrossRefPubMed
47.
Newton JR, MacKenzie WE, Emens MJ, Jordan JA: Division of uterine adhesions (Asherman’s syndrome) with the Nd-YAG laser. Br J Obstet Gynaecol. 1989, 96: 102-104. 10.1111/j.1471-0528.1989.tb01584.x.CrossRefPubMed
48.
Emanuel MH: New developments in hysteroscopy. Best Pract Res Clin Obstet Gynaecol. 2013, 27: 421-429. 10.1016/j.bpobgyn.2012.11.005.CrossRefPubMed
49.
McComb PF, Wagner BL: Simplified therapy for Asherman’s syndrome. Fertil Steril. 1997, 68: 1047-1050. 10.1016/S0015-0282(97)00413-5.CrossRefPubMed
50.
Protopapas A, Shushan A, Magos A: Myometrial scoring: a new technique for the management of severe Asherman’s syndrome. Fertil Steril. 1998, 69: 860-864. 10.1016/S0015-0282(98)00036-3.CrossRefPubMed
51.
Chen FP, Soong YK, Hui YL: Successful treatment of severe uterine synechiae with transcervical resectoscopy combined with laminaria tent. Hum Reprod. 1997, 12: 943-947. 10.1093/humrep/12.5.943.CrossRefPubMed
52.
Roy KK, Baruah J, Sharma JB, Kumar S, Kachawa G, Singh N: Reproductive outcome following hysteroscopic adhesiolysis in patients with infertility due to Asherman’s syndrome. Arch Gynecol Obstet. 2010, 281: 355-361. 10.1007/s00404-009-1117-x.CrossRefPubMed
53.
Yu D, Li TC, Xia E, Huang X, Liu Y, Peng X: Factors affecting reproductive outcome of hysteroscopic adhesiolysis for Asherman’s syndrome. Fertil Steril. 2008, 89: 715-722. 10.1016/j.fertnstert.2007.03.070.CrossRefPubMed
54.
Kodaman P, Arici A: Intra-uterine adhesions and fertility outcome: how to optimize success?. Curr Opin Obstet Gynecol. 2007, 19: 207-214. 10.1097/GCO.0b013e32814a6473.CrossRefPubMed
55.
Pabuccu R, Atay V, Orhon E, Urman B, Ergun A: Hysteroscopic treatment of intrauterine adhesions is safe and effective in the restoration of normal menstruation and fertility. Fertil Steril. 1997, 68: 1141-1143. 10.1016/S0015-0282(97)00375-0.CrossRefPubMed
56.
Shokeir TA, Fawzy M, Tatongy M: The nature of intrauterine adhesions following reproductive hysteroscopic surgery as determined by early and late follow-up hysteroscopy: clinical implications. Arch Gynecol Obstet. 2008, 277: 423-427. 10.1007/s00404-007-0475-5.CrossRefPubMed
57.
Ventolini G, Zhang M, Gruber J: Hysteroscopy in the evaluation of patients with recurrent pregnancy loss. Surg Endosc. 2004, 18: 1782-1784. 10.1007/s00464-003-8258-y.CrossRefPubMed
58.
Polishuk WZ, Weinstein D: The Soichet intrauterine device in the treatment of intrauterine adhesions. Acta Eur Fertil. 1976, 7: 215-218.PubMed
59.
Vesce F, Jorizzo G, Bianciotto A, Gotti G: Use of the copper intrauterine device in the management of secondary amenorrhea. Fertil Steril. 2000, 73: 162-165. 10.1016/S0015-0282(99)00475-6.CrossRefPubMed
60.
March CM: Intrauterine adhesions. Obstet Gynecol Clin North Am. 1995, 22: 491-505.PubMed
61.
Tonguc EA, Var T, Yilmaz N, Batioglu S: Intrauterine device or estrogen treatment after hysteroscopic uterine septum resection. Int J Gynaecol Obstet. 2010, 109: 226-229. 10.1016/j.ijgo.2009.12.015.CrossRefPubMed
62.
63.
Lin X, Wei M, Li TC, Huang Q, Huang D, Zhou F, Zhang S: A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013, 170: 512-516. 10.1016/j.ejogrb.2013.07.018.CrossRefPubMed
64.
Ismajovich B, Lidor A, Confino E, David MP: Treatment of minimal and moderate intrauterine adhesions (Asherman syndrome). J Reprod Med. 1985, 30: 769-772.PubMed
65.
Amer MI, Abd-El-Maeboud KH: Amnion graft following hysteroscopic lysis of intrauterine adhesions. J Obstet Gynaecol Res. 2006, 32: 559-566. 10.1111/j.1447-0756.2006.00454.x.CrossRefPubMed
66.
Orhue AA, Aziken ME, Igbefoh JO: A comparison of two adjunctive treatments for intrauterine adhesions following lysis. Int J Gynaecol Obstet. 2003, 82: 49-56. 10.1016/S0020-7292(03)00030-4.CrossRefPubMed
67.
Pellicano M, Bramante S, Cirillo D, Palomba S, Bifulco G, Zullo F, Nappi C: Effectiveness of autocrosslinked hyaluronic acid gel after laparoscopic myomectomy in infertile patients: a prospective, randomized, controlled study. Fertil Steril. 2003, 80: 441-444. 10.1016/S0015-0282(03)00597-1.CrossRefPubMed
68.
Guida M, Acunzo G, Di Spiezio Sardo A, Bifulco G, Piccoli R, Pellicano M, Cerrota G, Cirillo D, Nappi C: Effectiveness of auto-crosslinked hyaluronic acid gel in the prevention of intrauterine adhesions after hysteroscopic surgery: a prospective, randomized, controlled study. Hum Reprod. 2004, 19: 1461-1464. 10.1093/humrep/deh238.CrossRefPubMed
69.
Metwally M, Watson A, Lilford R, Vandekerckhove P: Fluid and pharmacological agents for adhesion prevention after gynaecological surgery. Cochrane Database Syst Rev. 2006, 19: CD001298
70.
Reijnen MM, Falk P, van Goor H, Holmdahl L: The antiadhesive agent sodium hyaluronate increases the proliferation rate of human peritoneal mesothelial cells. Fertil Steril. 2000, 74: 146-151. 10.1016/S0015-0282(00)00571-9.CrossRefPubMed
71.
Carta G, Cerrone L, Iovenitti P: Postoperative adhesion prevention in gynecologic surgery with hyaluronic acid. Clin Exp Obstet Gynecol. 2004, 31: 39-41.PubMed
72.
Mais V, Cirronis MG, Peiretti M, Ferrucci G, Cossu E, Melis GB: Efficacy of auto-crosslinked hyaluronan gel for adhesion prevention in laparoscopy and hysteroscopy: a systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2012, 160: 1-5. 10.1016/j.ejogrb.2011.08.002.CrossRefPubMed
73.
Tsapanos VS, Stathopoulou LP, Papathanassopoulou VS, Tzingounis VA: The role of Seprafilm bioresorbable membrane in the prevention and therapy of endometrial synechiae. J Biomed Mater Res. 2002, 63: 10-14. 10.1002/jbm.10040.CrossRefPubMed
74.
Robertson D, Lefebvre G, Leyland N, Wolfman W, Allaire C, Awadalla A, Best C, Contestabile E, Dunn S, Heywood M, et al: Society of Obstetricians and Gynaecologists of Canada. SOGC clinical practice guidelines Adhesion prevention in gynaecological surgery. Int J Gynaecol Obstet. 2010, 111: 193-197. 10.1016/j.ijgo.2010.07.002.CrossRefPubMed
75.
Kim T, Ahn KH, Choi DS, Hwang KJ, Lee BI, Jung MH, Kim JW, Kim JH, Cha SH, Lee KH, et al: A randomized, multi-center, clinical trial to assess the efficacy and safety of alginate carboxymethylcellulosehyaluronic acid compared to carboxymethylcellulose hyaluronic acid to prevent postoperative intrauterine adhesion. J Minim Invasive Gynecol. 2012, 19: 731-736. 10.1016/j.jmig.2012.08.003.CrossRefPubMed
76.
Magos A: Hysteroscopic treatment of Asherman’s syndrome. Reprod Biomed Online. 2002, 4 (Suppl 3): 46-51.CrossRefPubMed
77.
Myers EM, Hurst BS: Comprehensive management of severe Asherman syndrome and amenorrhea. Fertil Steril. 2012, 97: 160-164. 10.1016/j.fertnstert.2011.10.036.CrossRefPubMed
78.
Farhi J, Bar-Hava I, Homburg R, Dicker D, Ben-Rafael Z: Induced regeneration of endometrium following curettage for abortion: a comparative study. Hum Reprod. 1993, 8: 1143-1144.PubMed
79.
Sher G, Fisch JD: Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod. 2000, 15: 806-809. 10.1093/humrep/15.4.806.CrossRefPubMed
80.
Takasaki A, Tamura H, Miwa I, Taketani T, Shimamura K, Sugino N: Endometrial growth and uterine blood flow: a pilot study for improving endometrial thickness in the patients with a thin endometrium. Fertil Steril. 2010, 93: 1851-1858. 10.1016/j.fertnstert.2008.12.062.CrossRefPubMed
81.
Zinger M, Liu JH, Thomas MA: Successful use of vaginal sildenafil citrate in two infertility patients with Asherman’s syndrome. J Womens Health (Larchmt). 2006, 15: 442-444. 10.1089/jwh.2006.15.442.CrossRef
82.
Gargett CE, Nguyen HP, Ye L: Endometrial regeneration and endometrial stem/progenitor cells. Rev Endocr Metab Disord. 2012, 13: 235-251. 10.1007/s11154-012-9221-9.CrossRefPubMed
83.
Nagori CB, Panchal SY, Patel H: Endometrial regeneration using autologous adult stem cells followed by conception by in vitro fertilization in a patient of severe Asherman’s syndrome. J Hum Reprod Sci. 2011, 4: 43-48. 10.4103/0974-1208.82360.PubMedCentralCrossRefPubMed
84.
Rein DT, Schmidt T, Hess AP, Volkmer A, Schöndorf T, Breidenbach M: Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol. 2011, 18: 774-778. 10.1016/j.jmig.2011.08.003.CrossRefPubMed
85.
Tam WH, Lau WC, Cheung LP, Yuen PM, Chung TK: Intrauterine adhesions after conservative and surgical management of spontaneous abortion. J Am Assoc Gynecol Laparosc. 2002, 9: 182-185. 10.1016/S1074-3804(05)60129-6.CrossRefPubMed
86.
Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A: Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2011, 9: CD002855
87.
Neilson JP, Gyte GM, Hickey M, Vazquez JC, Dou L: Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2013, 28: 3-CD007223
Metadata
Title
The management of Asherman syndrome: a review of literature
Authors
Alessandro Conforti
Carlo Alviggi
Antonio Mollo
Giuseppe De Placido
Adam Magos
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2013
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-11-118

Other articles of this Issue 1/2013

Reproductive Biology and Endocrinology 1/2013 Go to the issue

Research

Ovarian HMW adiponectin is associated with folliculogenesis in women with polycystic ovary syndrome

Research

Sperm-associated antigen 11A is expressed exclusively in the principal cells of the mouse caput epididymis in an androgen-dependent manner

Research

Endometriosis fertility index score maybe more accurate for predicting the outcomes of in vitrofertilisation than r-AFS classification in women with endometriosis

Research

Does hormonal contraception prior to in vitro fertilization (IVF) negatively affect oocyte yields? - A pilot study

Research

Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval

Hypothesis

Embryonic diapause in humans: time to consider?